Abstract
BACKGROUND: Sibutramine, an inhibitor of serotonin and noradrenaline uptake, reduces appetite to cause weight loss. This study tested the hypothesis that an increase in energy expenditure also contributes to this weight loss. In addition, the effects of sibutramine on adrenaline induced changes in heart rate and cardiac output were determined
METHODS: Nineteen obese females randomly received either sibutramine 15 mg daily or placebo for 12 weeks along with dietary advice. Resting energy expenditure (REE) was measured and then energy expenditure was measured during a 30 min infusion of adrenaline (25 ng/min/kg IBW). Cardiac output and heart rate, measured by Duplex Colour Doppler ultrasonography, were similarly measured in the basal state and post adrenaline. All measurements were recorded at baseline and then after 12 weeks.
RESULTS: Ten patients who received sibutramine reduced their weight by 8.1±3.8% while 9 placebo treated subjects reduced their weight by 5.1±4.4%, P=0.13. In absolute terms, REE decreased in placebo subjects from 1500±201 kcal/24 h to 1357±231 kcal/24 h (9.4±9.9%) and in sibutramine subjects from 1540±184 kcal/24 h to 1444±128 kcal/24 h (5.3±12.0%), P=0.77. The increased weight loss in the sibutramine group was associated with an increase in the FFM adjusted REE (2.2±16.1%) unlike the expected decrease (5.8±9.5%) in the placebo group (P=0.11). There was some suggestion (P=0.09) that the usual positive correlation between loss of weight and decline in REE was lost in the sibutramine group (r=−0.30) compared with placebo (r=0.35). There was a negative correlation between loss of FFM and decline in REE/kg FFM and (P=0.029) which was not evident in placebo (P=0.83). Adrenaline induced energy expenditure was similar in the two groups at the end of the 12 week period and there were no significant cardiovascular changes between the two groups.
CONCLUSIONS: Sibutramine limits the decline in REE associated with weight loss, equivalent to about 100 kcal/d. This could allow greater numbers of people to maintain a greater degree of weight loss.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walsh, K., Leen, E. & Lean, M. The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females. Int J Obes 23, 1009–1015 (1999). https://doi.org/10.1038/sj.ijo.0801045
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801045
Keywords
This article is cited by
-
Role of obesity related inflammation in pathogenesis of peripheral artery disease in patients of type 2 diabetes mellitus
Journal of Diabetes & Metabolic Disorders (2023)
-
Counterfeit formulations: analytical perspective on anorectics
Forensic Toxicology (2021)
-
HPLC–UV Chromatographic Methods for Detection and Quantification of Undeclared Withdrawn Synthetic Medications in Counterfeit Herbal Medicines with Confirmation by HPLC–PDA and Mass Spectrometry
Chromatographia (2018)
-
Sibutramine Plus Meal Replacement Therapy for Body Weight Loss and Maintenance in Obese Patients
Obesity (2007)
-
Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials
International Journal of Obesity (2005)